World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
18767
World Ranking
2652
National Ranking
1268

Mark K. Slifka publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark K. Slifka sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 193 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark K. Slifka D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark K. Slifka sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark K. Slifka is affiliated with the Oregon National Primate Research Center in the United States. Their research primarily spans the field of Medicine, with a particular focus on Infectious Diseases, Epidemiology, and Molecular Biology. Additional areas of study include Public Health, Environmental and Occupational Health, as well as Oncology.

The scientist has produced significant work related to a variety of topics, including:

  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Gut microbiota and health
  • Viral Infections and Outbreaks Research
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Vectors

Among recent publications with Mark K. Slifka as an author or co-author, notable papers include:

  • Is presymptomatic spread a major contributor to COVID-19 transmission? (2020, Nature Medicine)
  • Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen (2021, Mucosal Immunology)
  • Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury (2020, Proceedings of the National Academy of Sciences)
  • Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules (2020, Clinical Infectious Diseases)
  • Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors (2021, Journal of Allergy and Clinical Immunology)

Frequent collaborators in their research include:

  • Archana Thomas
  • Lina Gao
  • Ilhem Messaoudi
  • Hans-Peter Raué
  • Ian J. Amanna

Mark K. Slifka has published regularly in several academic venues, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Allergy and Clinical Immunology
  • Clinical Infectious Diseases
  • PLoS Pathogens
  • The Journal of Immunology

Best Publications

  • Humoral immunity due to long-lived plasma cells

    Mark K Slifka;Rustom Antia;Jason K Whitmire;Rafi Ahmed

  • Duration of humoral immunity to common viral and vaccine antigens.

    Ian J. Amanna;Nichole E. Carlson;Mark K. Slifka

  • Duration of antiviral immunity after smallpox vaccination

    Erika Hammarlund;Matthew W Lewis;Scott G Hansen;Lisa I Strelow

  • The many important facets of T-cell repertoire diversity

    Janko Nikolich-Žugich;Mark K. Slifka;Ilhem Messaoudi

  • Clinical implications of dysregulated cytokine production

    M K Slifka;J L Whitton

  • Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

    Jessica L. Halliley;Jessica L. Halliley;Christopher M. Tipton;Jane Liesveld;Alexander F. Rosenberg

  • Functional avidity maturation of CD8 + T cells without selection of higher affinity TCR

    Mark K. Slifka;Mark K. Slifka;J. Lindsay Whitton

  • Bone marrow is a major site of long-term antibody production after acute viral infection

    Mark K. Slifka;Mehrdad Matloubian;Rafi Ahmed

  • Mechanisms that determine plasma cell lifespan and the duration of humoral immunity

    Ian J. Amanna;Mark K. Slifka

  • Rapid on/off cycling of cytokine production by virus-specific CD8 + T cells

    Mark K. Slifka;Fernando Rodriguez;J. Lindsay Whitton

  • Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox

    Erika Hammarlund;Matthew W Lewis;Shirley V Carter;Ian Amanna

  • Long-lived plasma cells: a mechanism for maintaining persistent antibody production

    Mark K Slifka;Rafi Ahmed

  • NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells

    Mark K. Slifka;Robb R. Pagarigan;J. Lindsay Whitton

  • Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity.

    Hao Shen;Mark K. Slifka;Mehrdad Matloubian;Eric R. Jensen

  • Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

    Ian J. Amanna;Mark K. Slifka

  • Immunity and immunological memory following smallpox vaccination.

    Ian J. Amanna;Mark K. Slifka;Shane Crotty

  • Regulation of innate CD8+ T-cell activation mediated by cytokines

    Bailey E. Freeman;Erika Hammarlund;Hans Peter Raué;Mark K. Slifka

  • Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

    Iuliia Gilchuk;Pavlo Gilchuk;Pavlo Gilchuk;Gopal Sapparapu;Rebecca Lampley

  • Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro

    Ralph Feuer;Ignacio Mena;Robb Pagarigan;Mark K. Slifka

  • Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

    Mark K. Slifka;J. Lindsay Whitton

  • How do viral infections predispose patients to bacterial infections

    Carol Beadling;Mark K Slifka

Frequent Co-Authors

Rafi Ahmed
Rafi Ahmed Emory University
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
J. Lindsay Whitton
J. Lindsay Whitton Scripps Research Institute
David C. Parker
David C. Parker Oregon Health & Science University
Klaus Früh
Klaus Früh Oregon Health & Science University
Jason K. Whitmire
Jason K. Whitmire University of North Carolina at Chapel Hill
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students consider advancing their education through programs like the cheapest pmhnp programs online, which offer specialized training in psychiatric nursing alongside foundational biological sciences.

Understanding compensation trends is essential when planning a career path. A doctorate in nursing salary varies by location, emphasizing the importance of research when selecting where to study or practice.

For nurses aiming to specialize, transitioning from a family nurse practitioner to an acute care nurse practitioner is a strategic move. Guidance on this process can be found in detailed resources like fnp to acnp, helping professionals shift toward urgent and critical care environments.

Accelerated learning options also exist for those eager to enter the field quickly. Many students benefit from an accelerated nurse practitioner program, which condenses essential coursework without sacrificing quality or accreditation.

Best Scientists Citing Mark K. Slifka

Trending Scientists

Recently Published Articles